Press releases
* (R) = Regulatory press releases
Jun 11, 2024
(R) Cantargia strengthen management team with the appointment of Ton Berkien as Chief Business Officer
Jun 1, 2024
Cantargia ASCO presentation highlights positive clinical data on nadunolimab counteracting neuropathy
May 23, 2024
(R) Cantargia presents new positive clinical data on nadunolimab counteracting chemotherapy induced neuropathy
May 23, 2024
(R) Annual General Meeting in Cantargia AB (publ)
May 7, 2024
Invitation to presentation of Cantargia’s interim report for Q1 2024 on May 21 at 3.00 p.m. CEST
Apr 18, 2024
